Fundraising Fox
Deep Genomics
Toronto, CA · Founded 2014 · 112 employees on LinkedIn · 9 known investors
Find your way into Deep Genomics
4,011 people in our graph can introduce you to the Deep Genomics team.
Sign up to see every warm intro you have to Deep Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deep Genomics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery. Its platform combines lab-in-the-loop workflows, training datasets, and screening technologies to find candidates for developing new medicines.
Founders & leadership
Deep Genomics was founded in 2014 by Brendan Frey.
BF
Brendan FreyFounderBrendan Frey founded Deep Genomics in 2015 to develop machine learning approaches for genetic medicine and drug discovery. He is a professor of engineering and medicine at the University of Toronto and has authored over 200 peer-reviewed papers on machine learning and genomics, including contributions to Nature, Science, and Cell.
BO
Brian O'CallaghanChief Executive OfficerBrian O'Callaghan is CEO of Deep Genomics and brings over 30 years of life sciences experience, including senior management and board roles at biotech, pharmaceutical, and contract research organizations across North America and Europe. His background spans public and private companies at various development stages, with expertise in business development, M&A, fundraising, and operational leadership.
DJ
David JohnstonChief Financial OfficerHe has held senior financial leadership roles at ImmunoGen, Aveo Oncology, and Genzyme Biosurgery, where he oversaw public offerings and strategic financing initiatives, and holds degrees from Washington and Lee University and the University of Michigan.
CB
Clive BertramChief Business OfficerHe has held commercial and business development roles across pharmaceutical, biotech, and medical device companies, with experience in product lifecycle management, licensing, and M&A transactions.
TM
Tom MastersonChief Operating OfficerHe previously worked in medical devices, contract research, and healthcare strategy, and founded Caregiver Support Technologies, a digital platform for family caregivers. He holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia and an M.B.A. from Harvard Business School.
GH
Greg HoffmanChief Scientific OfficerA biophysicist and cell biologist, he has spent over 10 years in the biotech industry leading teams on genomic screening, small molecule discovery, synthetic biology, and cell and gene therapy development.
Investors · 9
11.2 Capitallisted by 11.2 CapitalLas Vegas · $500K – $3M
How we know: 11.2 Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Bloomberg Betalisted by Bloomberg BetaSan Francisco · $25K – $1M
How we know: the VCSheet dataset · github.com · open dataset · 5k.vc investor directory · Not right? Tell us
Future Ventureslisted by Future VenturesLos Altos · $1M – $10M
How we know: Future Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Magnetic Ventureslisted by Magnetic VenturesBoston · $1M – $6M
How we know: Magnetic Ventures's portfolio page · Not right? Tell us
True Ventureslisted by True VenturesSan Francisco · $500K – $3Mvia Adam D'Augelli · led
How we know: True Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
Founder mafia
The Deep Genomics mafia →6 people who came through Deep Genomics went on to found or lead other companies.
Nessan BerminghamBoard MemberFounded Korro Bio +2Paul SekhriMember Board of DirectorsFounded VtvtherapeuticsPhilip FradkinBioinformaticianFounded Blank BioDorsa RohaniMachine Learning InternFounded MosaicBrian O'CallaghanChief Executive OfficerFounded Acucela Inc.Thong Q. LeMember Board of DirectorsFounded Automera
Related companies · 4
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Genomics PlcGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
10X Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
IDbyDNAScalable, high throughput DNA sequencing platforms.
Companies working in the same space as Deep Genomics.
Frequently asked questions
- What does Deep Genomics do?
- Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery. Its platform combines lab-in-the-loop workflows, training datasets, and screening technologies to find candidates for developing new medicines.
- Who founded Deep Genomics?
- Deep Genomics was founded by Brendan Frey in 2014.
- Who are Deep Genomics's investors?
- Deep Genomics's investors include 11.2 Capital, Bloomberg Beta, Future Ventures, Kensington Capital Partners Limited, Magnetic Ventures, SoftBank Vision Fund, True Ventures, Creative Destruction Lab (CDL) and 1 more.
- Where is Deep Genomics headquartered?
- Deep Genomics is headquartered in Toronto, CA.